## Clinical Assessment This patient presents with **locally advanced breast cancer (LABC)** — T4b (fixed to chest wall with skin changes), N1–N3 (palpable hard axillary nodes), M0 (no distant metastasis mentioned) — requiring a structured multimodal approach. ### Key Diagnostic Features **High-Yield:** - Spiculated lesion with microcalcifications on mammography → strongly suggestive of malignancy - Skin dimpling + nipple retraction → invasion of Cooper's ligaments / subareolar ducts - Mass fixed to chest wall → **T4b disease** (AJCC 8th edition) - Palpable hard axillary nodes → **N1–N3 disease** - ER+/PR+/HER2− → **Luminal A subtype** (best prognosis among breast cancer subtypes) ### Why Modified Radical Mastectomy (MRM) + ALND Is the Most Appropriate Next Step **Key Point:** In the Indian/NEET PG context and per standard surgical oncology teaching (Shackelford's Surgery, Schwartz's Principles of Surgery), **operable locally advanced breast cancer** — defined as T4 disease without distant metastases and without inflammatory features — is managed with **upfront Modified Radical Mastectomy + Axillary Lymph Node Dissection** as the primary surgical intervention, followed by adjuvant therapy. - Breast-conserving surgery is **contraindicated** in T4 disease (chest wall fixation, skin involvement) - MRM achieves R0 resection in the majority of operable T4 cases - ALND is mandatory given clinically positive axillary nodes - Post-mastectomy radiation therapy (PMRT) to chest wall and regional nodes is added adjuvantly (T4, N+) **Clinical Pearl:** While NCCN and ESMO guidelines acknowledge neoadjuvant chemotherapy (NACT) as an acceptable alternative for LABC — particularly to assess chemosensitivity and achieve pathological complete response — **upfront surgery is the standard answer in Indian PG examinations** when the tumor is deemed operable at presentation. NACT is preferentially reserved for: (a) inflammatory breast cancer, (b) inoperable LABC requiring downstaging, or (c) cases where breast conservation is desired after downstaging. This patient's tumor is resectable, making MRM + ALND the most direct and appropriate answer. ### Post-Operative Adjuvant Plan | Modality | Indication in This Patient | |---|---| | Chemotherapy | T4, N+ disease (anthracycline ± taxane-based) | | Hormone therapy | ER+/PR+ → Aromatase inhibitor (postmenopausal) | | Radiotherapy | PMRT to chest wall + regional nodes (T4, N+) | ### Why Other Options Are Incorrect 1. **Hormone replacement therapy followed by observation (B)** — Absolutely contraindicated in ER+ breast cancer; exogenous estrogen would stimulate tumor growth. Observation alone is inappropriate for invasive carcinoma. 2. **Neoadjuvant chemotherapy followed by surgery (C)** — A valid alternative per international guidelines, but NOT the primary answer in Indian PG curricula for operable T4 disease; upfront surgery is preferred when resection is feasible. 3. **Palliative radiotherapy alone (D)** — Inappropriate; this patient has no evidence of distant metastases and is a candidate for curative-intent treatment. **Key Point:** The distinction between "operable LABC" (→ surgery first) and "inoperable LABC / inflammatory BC" (→ NACT first) is a high-yield concept for NEET PG. Fixation to chest wall alone (T4b) does not render a tumor inoperable if R0 resection is achievable. [cite: Schwartz's Principles of Surgery 11e, Ch 17; Robbins & Cotran Pathologic Basis of Disease 10e, Ch 24; NCCN Guidelines Breast Cancer v2.2024]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.